{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:47:00Z","timestamp":1792806420944,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ymgme.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T13:28:24Z","timestamp":1434374904000},"page":"4-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":571,"title":["MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options"],"prefix":"10.1016","volume":"116","author":[{"given":"Ayman W.","family":"El-Hattab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle M.","family":"Adesina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Scaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2015.06.004_bb0005","series-title":"Inborn Errors of Metabolism: From Neonatal Screening to Metabolic Pathways","first-page":"180","article-title":"Mitochondrial disorders","author":"El-Hattab","year":"2015"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0010","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410160409","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome","volume":"16","author":"Pavlakis","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0015","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0020","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0006-291X(05)80860-5","article-title":"A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes)","volume":"173","author":"Kobayashi","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0025","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","article-title":"MELAS: an original case and clinical criteria for diagnosis","volume":"2","author":"Hirano","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0030","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0035","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1086\/301959","article-title":"Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population","volume":"63","author":"Majamaa","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0040","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.21196","article-title":"Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children","volume":"62","author":"Uusimaa","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0045","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/088307389400900102","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts","volume":"9","author":"Hirano","year":"1994","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0050","series-title":"GeneReviews\u00ae","article-title":"MELAS","author":"DiMauro","year":"2013"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0055","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1196\/annals.1444.011","article-title":"Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome","volume":"1142","author":"Sproule","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0060","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1212\/01.WNL.0000120557.83907.A8","article-title":"Cerebral lactic acidosis correlates with neurological impairment in MELAS","volume":"62","author":"Kaufmann","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0065","doi-asserted-by":"publisher","DOI":"10.1177\/0883073814567539","article-title":"Focal and generalized seizures may occur in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) patients","author":"Finsterer","year":"2015","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0070","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s002340050505","article-title":"MELAS presenting as migraine complicated by stroke: case report","volume":"39","author":"Ohno","year":"1997","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0075","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00415-003-0981-8","article-title":"Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA","volume":"250","author":"K\u00e4rpp\u00e4","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0080","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/archneur.63.5.746","article-title":"Nerve conduction abnormalities in patients with MELAS and the A3243G mutation","volume":"63","author":"Kaufmann","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0085","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4088\/JCP.11r07237","article-title":"The psychiatric manifestations of mitochondrial disorders: a case and review of the literature","volume":"73","author":"Anglin","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0090","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1001\/archneur.64.11.1625","article-title":"Wolff\u2013Parkinson\u2013White syndrome in patients with MELAS","volume":"64","author":"Sproule","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0095","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/hrt.80.3.292","article-title":"A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)","volume":"80","author":"Okajima","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0100","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.2169\/internalmedicine.43.1126","article-title":"Gastric dysmotility associated with accumulation of mitochondrial A3243G mutation in the stomach","volume":"43","author":"Fujii","year":"2004","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0105","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.2337\/diabetes.53.2007.S103","article-title":"Mitochondrial diabetes: molecular mechanisms and clinical presentation","volume":"53","author":"Maassen","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0110","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/jmg.33.7.621","article-title":"Nephropathy and growth hormone deficiency in a patient with mitochondrial tRNA(Leu(UUR)) mutation","volume":"33","author":"Yorifuji","year":"1996","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0115","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/088307380001501108","article-title":"Endocrine disorders in two sisters affected by MELAS syndrome","volume":"15","author":"Balestri","year":"2000","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0120","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0887-8994(98)00006-X","article-title":"mtDNA nt3243 mutation, external ophthalmoplegia, and hypogonadism in an adolescent girl","volume":"18","author":"Topalo\u011flu","year":"1998","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0125","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2169\/internalmedicine.39.249","article-title":"Diabetes mellitus, deafness, muscle weakness and hypocalcemia in a patient with an A3243G mutation of the mitochondrial DNA","volume":"39","author":"Tanaka","year":"2000","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0130","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1046\/j.1523-1755.2001.0590041236.x","article-title":"Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation","volume":"59","author":"Hotta","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0135","first-page":"1625","article-title":"Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A>G)","volume":"64","author":"Sproule","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0140","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1046\/j.1365-2133.1999.02761.x","article-title":"Increased prevalence of vitiligo, but no evidence of premature ageing, in the skin of patients with bp 3243 mutation in mitochondrial DNA in the mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome (MELAS)","volume":"140","author":"Karvonen","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0145","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0190-9622(99)70123-4","article-title":"Skin manifestations of a patient with mitochondrial encephalomyopathy with lactic acidosis and strokelike episodes (MELAS syndrome)","volume":"41","author":"Kubota","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0150","first-page":"100","article-title":"Chronic anemia as a manifestation of MELAS syndrome","volume":"63","author":"Finsterer","year":"2011","journal-title":"Rev. Investig. Clin."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0155","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mus.20807","article-title":"Pathogenic mitochondrial DNA mutations in protein-coding genes","volume":"36","author":"Wong","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0160","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2377-13-8","article-title":"POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome","volume":"13","author":"Cheldi","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0165","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1128\/MCB.12.2.480","article-title":"Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes","volume":"12","author":"King","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0170","doi-asserted-by":"publisher","first-page":"19198","DOI":"10.1074\/jbc.M908734199","article-title":"The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes","volume":"275","author":"Chomyn","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0175","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/ana.410290606","article-title":"Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes","volume":"29","author":"Hasegawa","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0180","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1212\/WNL.42.3.545","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation","volume":"42","author":"Goto","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0185","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ymgme.2012.01.016","article-title":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","volume":"105","author":"El-Hattab","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0190","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ymgme.2012.06.018","article-title":"Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders","volume":"107","author":"El-Hattab","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0195","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biocel.2013.12.009","article-title":"Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome","volume":"48","author":"El-Hattab","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/jphysiol.2004.068197","article-title":"Effect of exercise training on endothelium-derived nitric oxide function in humans","volume":"561","author":"Green","year":"2004","journal-title":"J. Physiol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0210","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/pr.55.2.3","article-title":"The pharmacology of nitric oxide in the peripheral nervous system of blood vessels","volume":"55","author":"Toda","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0215","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jns.2004.11.026","article-title":"Hypocitrullinemia in patients with MELAS: an insight into the \u201cMELAS paradox\u201d","volume":"229\u2013230","author":"Naini","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0220","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbrc.2007.05.184","article-title":"The role of nitric oxide in muscle fibers with oxidative phosphorylation defects","volume":"359","author":"Tengan","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0225","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.bbadis.2012.01.010","article-title":"Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS","volume":"1822","author":"Desquiret-Dumas","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0230","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0235","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M110.002964","article-title":"Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement","volume":"10","author":"Vattemi","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0240","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"l-Arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0245","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mito.2014.07.008","article-title":"Glucose metabolism derangements in adults with the MELAS m.3243A>G mutation","volume":"18","author":"El-Hattab","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0250","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1152\/physiol.00012.2007","article-title":"Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension","volume":"22","author":"Jonk","year":"2007","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0255","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2011.138","article-title":"The role of mitochondria in insulin resistance and type 2 diabetes mellitus","volume":"8","author":"Szendroedi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0260","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/jnnp-2012-303528","article-title":"The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation\u2014implications for diagnosis and management","volume":"84","author":"Nesbitt","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0265","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/adc.82.5.407","article-title":"Heterogeneous presentation in A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene","volume":"82","author":"Koga","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0270","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/jnnp.61.1.47","article-title":"The A to G transition at nt 3243 of the mitochondrial tRNALeu(UUR) may cause an MERRF syndrome","volume":"61","author":"Fabrizi","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0275","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/archneur.63.12.1701","article-title":"Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation","volume":"63","author":"Jeppesen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0280","first-page":"287432","article-title":"Mitochondrial sensorineural hearing loss: a retrospective study and a description of cochlear implantation in a MELAS patient","volume":"2012","author":"Scarpelli","year":"2012","journal-title":"Genet. Res. Int."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0285","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbabio.2004.09.007","article-title":"Implications of exercise training in mtDNA defects\u2014use it or lose it?","volume":"1659","author":"Taivassalo","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0290","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2165\/00023210-200620060-00002","article-title":"The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options","volume":"20","author":"Scaglia","year":"2006","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.ymgme.2015.06.004_bb0295","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mito.2006.11.006","article-title":"MELAS and l-arginine therapy","volume":"2007","author":"Koga","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0300","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","article-title":"Endothelial dysfunction in MELAS improved by l-arginine supplementation","volume":"66","author":"Koga","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0305","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mgene.2013.09.001","article-title":"The effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome","volume":"1","author":"El-Hattab","year":"2013","journal-title":"Meta Gene"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0310","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000117445","article-title":"Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study","volume":"37","author":"Chen","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0315","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mus.21758","article-title":"A randomized trial of coenzyme Q10 in mitochondrial disorders","volume":"42","author":"Glover","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0320","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0325","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mus.20688","article-title":"Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders","volume":"35","author":"Rodriguez","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0330","doi-asserted-by":"publisher","first-page":"S981","DOI":"10.1007\/s100720070015","article-title":"Long-term treatment with idebenone and riboflavin in a patient with MELAS","volume":"21","author":"Napolitano","year":"2000","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0335","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.neurol.2011.02.038","article-title":"Effect of long-term oral treatment with l-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient","volume":"167","author":"Lekoubou","year":"2011","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0340","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-0404.1995.tb01697.x","article-title":"CPEO and carnitine deficiency overlapping in MELAS syndrome","volume":"92","author":"Hsu","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0345","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s004310050663","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy","volume":"156","author":"Lam","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0350","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11011-006-9039-9","article-title":"Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA","volume":"22","author":"Lin","year":"2007","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0355","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1517\/17425255.2012.644535","article-title":"Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders","volume":"8","author":"Finsterer","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ymgme.2015.06.004_bb0360","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2015.06.004_bb0365","doi-asserted-by":"publisher","first-page":"L1211","DOI":"10.1152\/ajplung.00291.2006","article-title":"Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis","volume":"292","author":"van der Toorn","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921530024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921530024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T20:49:27Z","timestamp":1566852567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921530024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":73,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S109671921530024X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.06.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}